• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

    3/24/23 8:21:34 AM ET
    $AMPE
    $APTX
    $BOXD
    $BRDS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMPE alert in real time by email

    Gainers

    • Bird Global, Inc. (NYSE:BRDS) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this spring.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) gained 24.3% to $2.09 in pre-market trading after jumping 25% on Thursday. Maxim Group maintained Dermata Therapeutics with a Buy and lowered the price target from $16 to $4.
    • Siyata Mobile Inc. (NASDAQ:SYTA) gained 23.8% to $0.2097 in pre-market trading.
    • Clean Energy Technologies, Inc. (NASDAQ:CETY) climbed 22.8% to $4.88 in pre-market trading. Clean Energy Technologies reported the pricing of its underwritten public offering of 975,000 shares of common stock at $4.00 per share.
    • Troika Media Group, Inc. (NASDAQ:TRKA) rose 19.6% to $0.2136 in pre-market.
    • Aptinyx Inc. (NASDAQ:APTX) shares rose 18.3% to $0.2110 in pre-market trading. Aptinyx was granted European patent titled 'Spiro-lactam Nmda Receptor Modulators And Uses Thereof (for The Treatment Of Conditions Such As Depression And Related Disorders).'
    • Disc Medicine Opco Inc (NASDAQ:IRON) gained 16.5% to $26.61 in pre-market trading after gaining over 5% on Thursday. BMO Capital initiated coverage on Disc Medicine with an Outperform rating and announced a price target of $40.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) shares rose 14.4% to $0.6101 in pre-market trading. Virgin Orbit said on Thursday that it is in talks with "interested parties" about an investment in the company.
    • Heron Therapeutics, Inc. (NASDAQ:HRTX) rose 11.8% to $2.31 in pre-market trading after posting upbeat Q4 results.
    • Helbiz, Inc. (NASDAQ:HLBZ) shares rose 9.6% to $0.1241 in pre-market trading after declining around 4% on Thursday.

    Losers

    • Boxed, Inc. (NYSE:BOXD) fell 24.4% to $0.26 in pre-market trading after gaining 91% on Thursday. Boxed recently said it is evaluating potentially filing for relief under the U.S. Bankruptcy Code and other strategic alternatives.
    • DiamondHead Holdings Corp. (NASDAQ:DHHC) fell 12.8% to $16.50 in pre-market trading after gaining more than 82% on Thursday. DiamondHead entered into convertible note purchase agreement dated March 21, 2023.
    • Ampio Pharmaceuticals, Inc. (NYSE:AMPE) fell 11.3% to $0.2050 in pre-market after dropping more than 10% on Thursday.
    • FiscalNote Holdings, Inc. (NYSE:NOTE) fell 10.1% to $2.14 in pre-market trading. FiscalNote shares jumped 75% on Thursday after the company announced it was selected by OpenAI for collaboration as an inaugural launch partner for OpenAI's ChatGPT plug-in.
    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares dropped 9.1% to $2.10 in pre-market trading after dropping over 20% on Thursday. TC Biopharm recently announced corporate restructuring.
    • HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) shares fell 6.9% to $3.12 in pre-market trading after gaining over 22% on Thursday.
    • Flora Growth Corp. (NASDAQ:FLGC) fell 6.4% to $0.2620 in pre-market trading. Flora Growth is expected to host its 2022 year-end earnings call on Monday, April 3, 2023.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares fell 6.2% to $1.21 in pre-market trading after jumping over 35% on Thursday.
    • Ouster, Inc. (NYSE:OUST) fell 6% to $0.8499 in pre-market trading after the company reported downbeat Q4 results and issued weak Q1 sales forecast.
    • Silvergate Capital Corporation (NYSE:SI) fell 5.3% to $1.07 in pre-market trading after dropping over 14% on Thursday.

    Now Read This: Top 5 Industrials Stocks That Are Ticking Portfolio Bombs

    Get the next $AMPE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMPE
    $APTX
    $BOXD
    $BRDS

    CompanyDatePrice TargetRatingAnalyst
    Ouster Inc.
    $OUST
    11/7/2025$33.00Neutral → Overweight
    Cantor Fitzgerald
    Disc Medicine Inc.
    $IRON
    11/3/2025$125.00Buy
    Stifel
    Shoulder Innovations Inc.
    $SI
    8/25/2025$20.00Buy
    Goldman
    Shoulder Innovations Inc.
    $SI
    8/25/2025$23.00Buy
    BTIG Research
    Shoulder Innovations Inc.
    $SI
    8/25/2025$18.00Overweight
    Piper Sandler
    Shoulder Innovations Inc.
    $SI
    8/25/2025$19.00Buy
    Jefferies
    Disc Medicine Inc.
    $IRON
    7/21/2025$86.00Buy
    Truist
    Disc Medicine Inc.
    $IRON
    7/3/2025$85.00Overweight
    Morgan Stanley
    More analyst ratings

    $AMPE
    $APTX
    $BOXD
    $BRDS
    SEC Filings

    View All

    SEC Form 20-F filed by SMX (Security Matters) Public Limited Company

    20-F - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    3/20/26 5:20:54 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    SEC Form 8-K filed by FiscalNote Holdings Inc.

    8-K - FiscalNote Holdings, Inc. (0001823466) (Filer)

    3/19/26 4:42:06 PM ET
    $NOTE
    Real Estate

    FiscalNote Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - FiscalNote Holdings, Inc. (0001823466) (Filer)

    3/19/26 4:18:18 PM ET
    $NOTE
    Real Estate

    $AMPE
    $APTX
    $BOXD
    $BRDS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FiscalNote Announces Strategic Partnership to Accelerate Generation and Monetization of Political Prediction Content

    Partnership With Good Wolf Studios Will Advance Development and Monetization of Prediction-Related Content and Interactive Experiences as FiscalNote Pursues First-of-its-Kind Transactional Monetization Opportunities FiscalNote Holdings, Inc. (NYSE:NOTE), a leading provider of AI-driven policy and regulatory intelligence, today announced that it has entered into an agreement with Good Wolf Studios to support and accelerate the development and monetization of prediction market-related content and interactive user experiences. This initiative represents another step in FiscalNote's broader strategy to participate in the rapidly growing prediction market ecosystem by leveraging its proprietar

    3/23/26 7:01:00 AM ET
    $NOTE
    Real Estate

    FiscalNote Expands Access to Its U.S. Policy Intelligence Across Asian Markets Through Partnership with Advisory Arm of Leading Korean Law Firm, D&A LLC

    Memorandum of Understanding (MOU) Establishes Foundation for Long-Term Collaboration to Expand Access to Trusted U.S. Legislative and Regulatory Intelligence Across Asia FiscalNote Holdings, Inc. (NYSE:NOTE), a global leader in AI-driven policy and regulatory intelligence, today announced a Memorandum of Understanding (MOU) with D&A Advisory LLC, the Washington, D.C.-based consulting arm of D&A LLC, one of South Korea's premier law firms. The MOU establishes a foundation for long-term collaboration to bring FiscalNote's authoritative U.S. policy intelligence to Korean and Asian enterprises, law firms, and government affairs professionals across Asia. As Korean and Asian organizations fa

    3/20/26 2:14:00 PM ET
    $NOTE
    Real Estate

    CETY Engages in Strategic Project Discussions at Bioenergy Association of California Annual Meeting

    Company advances California pilot initiative and expands pipeline of waste-to-energy opportunities IRVINE, CA, March 20, 2026 (GLOBE NEWSWIRE) -- Clean Energy Technologies, Inc. (NASDAQ:CETY) ("CETY" or the "Company"), a clean energy company focused on converting waste into renewable energy, announced its participation in the Bioenergy Association of California (BAC) annual meeting held March 17 in Sacramento, where the Company engaged in active project discussions on advancing a California pilot waste-to-clean energy initiative. CETY's participation as an active BAC member comes at a time of accelerating demand for technologies that convert organic waste into renewable electricity, pipe

    3/20/26 8:45:00 AM ET
    $CETY
    Metal Fabrications
    Consumer Discretionary

    $AMPE
    $APTX
    $BOXD
    $BRDS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMPE
    $APTX
    $BOXD
    $BRDS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

    4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)

    3/17/26 5:44:21 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:42:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buckman Paul exercised 45,606 shares at a strike of $2.26 and covered exercise/tax liability with 7,006 shares, increasing direct ownership by 192% to 58,704 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:38:10 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $AMPE
    $APTX
    $BOXD
    $BRDS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $AMPE
    $APTX
    $BOXD
    $BRDS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Ouster upgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald upgraded Ouster from Neutral to Overweight and set a new price target of $33.00

    11/7/25 8:00:24 AM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    Stifel resumed coverage on Disc Medicine with a new price target

    Stifel resumed coverage of Disc Medicine with a rating of Buy and set a new price target of $125.00

    11/3/25 9:08:29 AM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Goldman initiated coverage on Shoulder Innovations with a new price target

    Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00

    8/25/25 8:23:10 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

    4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)

    3/17/26 5:44:21 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $30,000 worth of shares (2,000 units at $15.00), increasing direct ownership by 27% to 70,785 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:42:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Director Buchholz Richard bought $14,840 worth of shares (1,000 units at $14.84), increasing direct ownership by 8% to 13,666 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    3/17/26 5:34:29 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $AMPE
    $APTX
    $BOXD
    $BRDS
    Leadership Updates

    Live Leadership Updates

    View All

    Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors

    GRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board.   "Drew is a proven healthcare leader, and we are thrilled to welcome him to S

    3/2/26 7:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer

    WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Lisa Amaya Price, MBA as the company's Chief Human Resources (HR) Officer. Ms. Amaya Price brings more than 25 years of experience in human resources and organizational leadership, including at multiple commercial-stage companies. "As we move towards commercialization, we have meaningfully increased hiring to support these efforts and Lisa will play a central role in building a strong, scal

    1/12/26 4:30:00 PM ET
    $IRON
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Ouster Appoints Phil Eyler to Board of Directors

    Mr. Eyler brings 30+ years of electronics, software and sensing expertise, particularly in the automotive industry, to the Company Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a global leader in high-performance lidar sensors and intelligent software solutions that bring Physical AI to life, announced today the appointment of Phillip M. Eyler to its Board of Directors. Mr. Eyler will also serve on the Compensation Committee of the Board. Mr. Eyler brings more than 30 years of engineering, operations, and business expertise to the Ouster Board, including a wealth of experience developing and selling hardware and software solutions for the automotive and industrial markets. He ha

    12/10/25 4:15:00 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    $AMPE
    $APTX
    $BOXD
    $BRDS
    Financials

    Live finance-specific insights

    View All

    FiscalNote Reports Fourth Quarter and Full Year 2025 Financial Results

    Total Revenue Meets and Adjusted EBITDA Exceeds Guidance for Q4 and Full Year 2025 AI Deployment and Related Organizational Transformation to Drive Workforce Reduction of Approximately 25%; Company Anticipates Positive Free Cash Flow on a Trailing Twelve Month Basis by End of Q1 2027 New Product Initiatives Take Advantage of Large Growth Opportunities in Agentic AI-Driven Data Consumption and Political Prediction Markets Board of Directors Continues to Review All Strategic Options Available to the Company to Maximize Shareholder Value Company To Host Conference Call Today at 5:00 PM ET FiscalNote Holdings, Inc. (NYSE:NOTE) ("FiscalNote" or the "Company"), a global leader in AI-dri

    3/19/26 4:15:00 PM ET
    $NOTE
    Real Estate

    Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter Net Revenue Growth Accelerates to 65% Year-Over-YearGRAND RAPIDS, Mich., March 10, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial HighlightsGenerated net revenue of $14.4 million in the fourth quarter, a 65% increase over the prior year quarterGenerated net revenue of $47.3 million for the full y

    3/10/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Ouster Announces Results for Fourth Quarter and Full Year 2025

    Record revenue and gross margins, achieving 12th straight quarter of product revenue growth Record quarterly lidar shipments of 8,100 units; 2025 shipments exceed 25,000 Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, announced today financial results for the three months and year ended December 31, 2025. "2025 was a year of exceptional execution for Ouster. Our strong revenue growth and gross margin performance are a testament to our disciplined focus as we pioneer the technologies driving the secular shift towards Physical AI, delivering record results," said Ouster CEO Angus Pacala. "As we look forward, the strength of our

    3/2/26 4:10:00 PM ET
    $OUST
    Industrial Machinery/Components
    Industrials

    $AMPE
    $APTX
    $BOXD
    $BRDS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Siyata Mobile Inc.

    SC 13G/A - Siyata Mobile Inc. (0001649009) (Subject)

    11/14/24 7:28:44 PM ET
    $SYTA
    Telecommunications Equipment
    Telecommunications